Compare AbCellera Biologics Inc (ABCL) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Manulife Financial Corporation — how do they compare? AbCellera Biologics Inc trades at $9.18 (market cap $2.99B), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: Manulife Financial Corporation is far larger — about 24.3× AbCellera Biologics Inc's market cap, and Manulife Financial Corporation pays a 3.1% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MFC | |
|---|---|---|
Market Cap | $2.99B | $72.68B |
Sector | Health | Financials |
52-Week High | $9.76 | $44.77 |
52-Week Low | $2.78 | $30.06 |
Enterprise Value | $2.58B | $67.84B |
Dividend Yield | — | 3.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
